Patent ID: 8859768
Filing Date: 2014-10-14
Classification: A61K,A61P,C07D

Abstract:
1. A compound of formula IB: or a pharmaceutically acceptable salt thereof, wherein: G R R each occurrence of R T HY is a group selected from: wherein each occurrence of X wherein R each occurrence of R provided that: a. when G b. when HY is unsubstituted 3-pyridinyl, then neither R c. when HY is 4-pyridinyl, then HY is not tetra substituted; and d. the compound is other than: 2-Pyrimidinamine, 4-[4-(4-fluorophenyl)-2-(4-pyridinyl)-5-oxazolyl]-N-[(1S)-1-phenylethyl]-; Ethanone, 1-[5-(4-chlorophenyl)-2-(4-pyridinyl)-4-oxazolyl]-; Pyridine, 4-[4-chloro-5-[4-(trichloromethyl)phenyl]-2-oxazolyl]-; Benzenepropanamide, α-[[4-[5-(3,4-dichlorophenyl)-2-(3-pyridinyl)-4-oxazolyl]benzoyl]amino]-, (αS)-; Benzoic acid, 4-[5-(3,4-dichlorophenyl)-2-(3-pyridinyl)-4-oxazolyl]-, methyl ester; Benzoic acid, 4-[5-(3,4-dichlorophenyl)-2-(3-pyridinyl)-4-oxazolyl]-; Pyridine, 3-[4-(4-chlorophenyl)-5-(4-methylphenyl)-2-oxazolyl]-4-methyl-; Pyridinium, 4-[4,5-bis(4-methoxyphenyl)-2-oxazolyl]-1-methyl-, perchlorate; or Benzenamine, 4-[5-(4-chlorophenyl)-2-(4-pyridinyl)-4-oxazolyl]-N,N-dimethyl-.